The production of recombinant biopharmaceuticals, e.g., antibody fragments and growth hormones, is a billion-dollar industry, with many therapeutic proteins being expressed in the bacterium Escherichia coli [1]. Most of the E. coli expression systems used for recombinant protein production (RPP) were constructed in the last century and many of them require an inducer molecule, such as IPTG (isopropyl-β-D-thiogalactoside), to switch on expression of the target protein [1]. However, such inducer molecules can be toxic to the cell, unstable and are extremely expensive, with IPTG exceeding £52000 per kg. To reduce the cost of RPP, we have used synthetic biology to engineer completely new E. coli RPP expression systems, which use cheap and freely available inducer molecules, such as nitrate and urea [2,3]. This was achieved by using different transcription factors to control the expression of industrially relevant targets protein. Thus, using our systems, we were able to show that proteins, such as human growth hormone (hGH), could be expressed to comparable levels seen with standard RPP systems. As many of our inducer molecules are freely available, this innovation demonstrated that controlled, high level RPP can be easily achieved using unconventional inducers (e.g., garden fertilizers and even urine!), drastically cutting the cost of RPP in areas of the world where infrastructure and resources are limited.
As the genomes of bacteria, such as E. coli, contain a multitude of transcription factors that respond to different environmental signals the goal of this project will be to design, construct, and test new recombinant protein production systems, that utilise and respond to cheap and freely available inducer molecules. This project will provide extensive training in many essential molecular biology, biochemical and biotechnology related techniques.
References: *Research from the supervisor’s laboratory
1*) Browning, D.F., Godfrey, R.E., Richards, K.L., Robinson, C. and Busby, S.J.W. (2019) Exploitation of the Escherichia coli lac operon promoter for controlled recombinant protein production. Biochemical Society Transactions. 47:755-763.
2*) Hothersall, J., Lai, S., Zhang, N., Godfrey, R.E., Ruanto, P., Bischoff, S., Robinson, C., Overton, T.W., Busby, S.J.W, Browning, D.F. (2022). Inexpensive protein overexpression driven by the NarL transcription activator protein. Biotechnology and Bioengineering. 119(6):1614-1623.
3*) Hothersall, J., Osgerby, A., Godfrey, R.E., Overton, T.W., Busby, S.J.W and Browning, D.F. (2022) New vectors for Urea-Inducible Recombinant Protein Production. New Biotechnology. In press